# Sumitomo Dainippon Pharma Co., Ltd. – FDA Inspection, Aug 7, 2025

Source: https://www.keypedia.com/records/fda_inspections/sumitomo-dainippon-pharma-co-ltd/43625239-cfee-4173-8772-0af3efdf143c
Source feed: FDA_Inspections

> FDA inspection 1277764 of Sumitomo Dainippon Pharma Co., Ltd., August 07, 2025. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1277764
- Company Name: Sumitomo Dainippon Pharma Co., Ltd.
- Inspection Date: 2025-08-07
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 3

## Related Documents

- [FDA Inspection 1113228 - 2019-11-22](https://www.keypedia.com/records/fda_inspections/sumitomo-dainippon-pharma-co-ltd/1c86b0d4-989e-4cae-ad7f-4339b52c4cd9)
- FDA Inspection 1064584 - 2018-07-27
- FDA Inspection 990466 - 2016-09-09
- FDA Inspection 853865 - 2013-11-01
- FDA Inspection 770009 - 2012-02-23

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/tekalign-wondimu/3b80e5c8-4062-4e1d-8ddd-b1afa2616dec)

Company: https://www.keypedia.com/companies/sumitomo-dainippon-pharma-co-ltd/40ead027-5fd5-4deb-a37b-40301cffd612

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8
